296 related articles for article (PubMed ID: 20691268)
1. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.
Larsen CA; Dashwood RH; Bisson WH
Pharmacol Res; 2010 Dec; 62(6):457-64. PubMed ID: 20691268
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
3. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
Shimizu M; Shirakami Y; Moriwaki H
Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
Nagle DG; Ferreira D; Zhou YD
Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
[TBL] [Abstract][Full Text] [Related]
5. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
[TBL] [Abstract][Full Text] [Related]
6. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic issues concerning cancer prevention by tea catechins.
Yang CS; Wang H
Mol Nutr Food Res; 2011 Jun; 55(6):819-31. PubMed ID: 21538856
[TBL] [Abstract][Full Text] [Related]
8. Green tea catechins: Proposed mechanisms of action in breast cancer focusing on the interplay between survival and apoptosis.
Yiannakopoulou ECh
Anticancer Agents Med Chem; 2014 Feb; 14(2):290-5. PubMed ID: 24069935
[TBL] [Abstract][Full Text] [Related]
9. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
Zaveri NT
Life Sci; 2006 Mar; 78(18):2073-80. PubMed ID: 16445946
[TBL] [Abstract][Full Text] [Related]
10. Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.
Colomer R; Sarrats A; Lupu R; Puig T
Curr Drug Targets; 2017; 18(2):147-159. PubMed ID: 26758667
[TBL] [Abstract][Full Text] [Related]
11. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.
Kondo T; Ohta T; Igura K; Hara Y; Kaji K
Cancer Lett; 2002 Jun; 180(2):139-44. PubMed ID: 12175544
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemoprevention with green tea catechins: from bench to bed.
Shirakami Y; Shimizu M; Moriwaki H
Curr Drug Targets; 2012 Dec; 13(14):1842-57. PubMed ID: 23140294
[TBL] [Abstract][Full Text] [Related]
14. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.
Connors SK; Chornokur G; Kumar NB
Nutr Cancer; 2012; 64(1):4-22. PubMed ID: 22098273
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
Muto S; Fujita K; Yamazaki Y; Kamataki T
Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
Jung YD; Ellis LM
Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
[TBL] [Abstract][Full Text] [Related]
17. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells.
Namiki K; Wongsirisin P; Yokoyama S; Sato M; Rawangkan A; Sakai R; Iida K; Suganuma M
Sci Rep; 2020 Feb; 10(1):2444. PubMed ID: 32051483
[TBL] [Abstract][Full Text] [Related]
19. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.
Zhang Q; Tang X; Lu Q; Zhang Z; Rao J; Le AD
Mol Cancer Ther; 2006 May; 5(5):1227-38. PubMed ID: 16731755
[TBL] [Abstract][Full Text] [Related]
20. Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.
Hu G; Zhang L; Rong Y; Ni X; Sun Y
Curr Drug Metab; 2014 Jan; 15(1):14-22. PubMed ID: 24329111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
